The STARMEN trial indicates that alternating treatment with corticosteroids and cyclophosphamide is superior to sequential treatment with tacrolimus and rituximab in primary membranous nephropathy

Details 詳細情報について

• CRID

  1360855571158018944

• DOI

  10.1016/j.kint.2020.10.014

• ISSN

  00852538

• Web Site

  https://api.elsevier.com/content/article/PII:S0085253820312515?httpAccept=text/xml

  https://api.elsevier.com/content/article/PII:S0085253820312515?httpAccept=text/plain

• Data Source

  • Crossref